PMS1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.991800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.197000E-01
Normal-vs-Stage2
3.988600E-01
Normal-vs-Stage3
1.338010E-01
Normal-vs-Stage4
6.432400E-01
Stage1-vs-Stage2
2.463400E-01
Stage1-vs-Stage3
9.379500E-02
Stage1-vs-Stage4
7.447400E-01
Stage2-vs-Stage3
1.744360E-01
Stage2-vs-Stage4
1.727010E-01
Stage3-vs-Stage4
1.652500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.091000E-01
Normal-vs-AfricanAmerican
2.521800E-01
Normal-vs-Asian
3.050200E-01
Caucasian-vs-AfricanAmerican
8.438200E-01
Caucasian-vs-Asian
1.381620E-01
AfricanAmerican-vs-Asian
1.955420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.897600E-01
Normal-vs-Female
4.157000E-01
Male-vs-Female
5.475400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.377800E-01
Normal-vs-Age(41-60Yrs)
4.194600E-01
Normal-vs-Age(61-80Yrs)
3.921400E-01
Normal-vs-Age(81-100Yrs)
4.100000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.861600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.613600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.813000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.149600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.431200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.846400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.757400E-01
Normal-vs-Daily Drinker
3.548200E-01
Normal-vs-Weekly Drinker
2.882200E-01
Normal-vs-Occasional Drinker
4.226600E-01
Normal-vs-Social Drinker
1.133980E-01
Non Drinker-vs-Daily Drinker
7.347800E-01
Non Drinker-vs-Weekly Drinker
5.786800E-01
Non Drinker-vs-Occasional Drinker
5.016800E-01
Non Drinker-vs-Social Drinker
5.964400E-01
Daily Drinker-vs-Weekly Drinker
4.692800E-01
Daily Drinker-vs-Occasional Drinker
3.215200E-01
Daily Drinker-vs-Social Drinker
4.361400E-01
Weekly Drinker-vs-Occasional Drinker
8.416400E-01
Weekly Drinker-vs-Social Drinker
8.375200E-01
Occasional Drinker-vs-Social Drinker
9.757800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.716640E-01
Normal-vs-Grade 2
6.042400E-02
Normal-vs-Grade 3
6.041700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.644000E-02
Grade 1-vs-Grade 3
1.036600E-01
Grade 1-vs-Grade 4
1.716640E-01
Grade 2-vs-Grade 3
9.317400E-01
Grade 2-vs-Grade 4
6.042400E-02
Grade 3-vs-Grade 4
6.041700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.582600E-01
Normal-vs-NonDiabetic
3.789800E-01
Diabetic-vs-NonDiabetic
6.248600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.386400E-01
Normal-vs-NoPancreatitis
3.815800E-01
Pancreatitis-vs-NoPancreatitis
4.689600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.902000E-01
Normal-vs-N1
4.072400E-01
N0-vs-N1
6.858400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.736600E-01
Normal-vs-TP53-NonMutant
4.760000E-01
TP53-Mutant-vs-TP53-NonMutant
9.664000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
